Pfizer-BioNTech Shot Could Help End Pandemic, Israel Study Shows

Feb. 24, 2021, 10:00 PM UTC

Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was overwhelmingly effective against the virus in a study that followed nearly 1.2 million people in Israel, results that public-health experts said show that immunizations could end the pandemic.

Two doses of the vaccine prevented 94% of Covid-19 cases in 596,618 people vaccinated between Dec. 20 and Feb. 1, about one-quarter of whom were over the age of 60, teams from the Clalit Research Institute and Harvard University reported in a study published Wednesday in the New England Journal of Medicine.

Watch: Medical researchers are saying the Pfizer-BioNTech shot could be the one to end the covid-19 pandemic.
(Source: Bloomberg)

The researchers matched each vaccinated person with someone who hadn’t ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.